COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

A Fendler, EGE de Vries… - Nature Reviews …, 2022‏ - nature.com
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

Diabetes and the COVID-19 pandemic

K Khunti, J Valabhji, S Misra - Diabetologia, 2023‏ - Springer
Almost immediately after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) virus emerged, it was evident that people with chronic diseases, including diabetes, were …

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double …

H Montgomery, FDR Hobbs, F Padilla… - The Lancet …, 2022‏ - thelancet.com
Background Early intramuscular administration of SARS-CoV-2-neutralising monoclonal
antibody combination, tixagevimab–cilgavimab, to non-hospitalised adults with mild to …

[HTML][HTML] Risk factors for severe COVID-19 outcomes among persons aged≥ 18 years who completed a primary COVID-19 vaccination series—465 health care …

C Yek - MMWR. Morbidity and Mortality Weekly Report, 2022‏ - cdc.gov
Among 1,228,664 persons who completed primary vaccination during December 2020–
October 2021, severe COVID-19–associated outcomes (0.015%) or death (0.0033%) were …

Severity of Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom

C Hyams, R Challen, R Marlow, J Nguyen… - The Lancet Regional …, 2023‏ - thelancet.com
Background There is an urgent public health need to evaluate disease severity in adults
hospitalised with Delta and Omicron SARS-CoV-2 variant infections. However, limited data …

Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy

A Haque, AB Pant - Journal of autoimmunity, 2022‏ - Elsevier
The emergence and rapid global spread of the new Delta and, more recently, Omicron
variants of SARS-CoV-2 pose a daunting public health emergency. Being an RNA virus, the …

The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery

K Khunti, VR Aroda, P Aschner, JCN Chan… - The Lancet Diabetes & …, 2022‏ - thelancet.com
The COVID-19 pandemic has disproportionately affected certain groups, such as older
people (ie,> 65 years), minority ethnic populations, and people with specific chronic …

[HTML][HTML] Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population …

C Piernas, M Patone, NM Astbury, M Gao… - The lancet Diabetes & …, 2022‏ - thelancet.com
Background A high BMI has been associated with a reduced immune response to
vaccination against influenza. We aimed to investigate the association between BMI and …

[HTML][HTML] The global impact of COVID-19 on solid organ transplantation: two years into a pandemic

A Nimmo, D Gardiner, I Ushiro-Lumb, R Ravanan… - …, 2022‏ - journals.lww.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …